The Health Pulse
🎙️ The Health Pulse – Your quick guide to better health!
In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful.
Listen, learn, and take control—one pulse at a time! 🔬✨
The Health Pulse
Episode 142 | The Normal Blood Sugar Trap
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
What does it actually mean to reverse type 2 diabetes? If medications bring your HbA1c back into the normal range, has the disease improved—or has the glucose simply been controlled?
In this episode of The Health Pulse, we examine a revealing clinical trial in people with newly diagnosed type 2 diabetes. An aggressive four-drug strategy normalized glucose in roughly 90% of participants during 16 weeks of treatment. But after the medications were withdrawn, that early advantage did not translate into higher rates of sustained, medication-free remission.
That difference exposes one of the most important concepts in metabolic health: normalizing a biomarker while treatment is being taken is not the same as changing the underlying disease state.
We begin with HbA1c, one of the most useful tools for diagnosing and monitoring diabetes, but a marker that cannot tell the entire metabolic story by itself. Glucose may improve while insulin resistance, hyperinsulinemia, ectopic fat, fatty liver, and cardiovascular risk remain.
We then follow type 2 diabetes deeper into the liver and pancreas. As excess energy begins accumulating in tissues that aren't designed to store large amounts of fat, lipid intermediates can interfere with insulin signaling. The insulin-resistant liver continues releasing glucose while the pancreas compensates by producing more insulin. Over time, increasing metabolic pressure can impair beta-cell function, including the rapid first-phase insulin response needed to control glucose after meals.
This helps explain why early intervention matters—and why diabetes risk can't be reduced to BMI alone. We explore the personal fat threshold, the idea that individuals differ in how much fat they can safely store before excess energy begins accumulating ectopically in organs such as the liver and pancreas.
From there, we examine strategies capable of reducing that metabolic pressure. Substantial weight loss when appropriate, carbohydrate restriction, resistance training, and metabolic surgery can reach the problem through different mechanisms. We explain how muscle contraction can stimulate glucose uptake through pathways involving AMPK and GLUT4 with less dependence on insulin, and how metabolic surgery can rapidly alter appetite, nutrient signaling, and gut hormones such as GLP-1.
Finally, we discuss what deeper metabolic monitoring can add beyond HbA1c, including fasting insulin, HOMA-IR, C-peptide, triglycerides, and ApoB. These markers can provide additional context about insulin demand, endogenous insulin production, lipid metabolism, and cardiovascular risk.
Remission is an extraordinary goal, but it shouldn't be confused with a cure. Even after glucose returns to the non-diabetic range without glucose-lowering medication, long-term monitoring remains important because metabolic dysfunction and hyperglycemia can return.
If you're tracking type 2 diabetes using HbA1c alone, this episode will help you ask a more important question: are we simply lowering the glucose—or reducing the metabolic pressure that made it rise in the first place?
📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required.
📅 Book your appointment or learn more at:
👉 Quick Lab Mobile
📧 Contact us: info@quicklabmobile.com
💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.
Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Normal Numbers, Hidden Metabolic Fire
NicoletteWelcome to the Health Post, your go-to source for quick, actionable insights on health, wellness, and diagnostics. Whether you're looking to optimize your well-being or stay informed about the latest in-medical testing, we've got you covered. Join us as we break down key health topics in just minutes. Let's dive in.
RachelImagine a clinical trial, right? Where um 90% of newly diagnosed patients are just essentially cured of high blood sugar in like 16 weeks.
MarkI mean, that sounds like a total medical triumph. The kind of data that it rewrites standard of care overnight.
RachelExactly. But then the researchers took those same patients off the drugs, and the success rate completely crashed, like down to 38%.
MarkWow. So they actually performed worse than the control group receiving standard care.
RachelYeah, exactly worse. So today we're doing a deep dive into why a perfectly normal blood sugar reading on your lab report might, you know, just be an elaborate smokescreen for a massive hidden metabolic fire.
MarkIt really forces us to completely reevaluate what a normal lab result actually means for your body, because modern pharmacology is, frankly, staggering in its ability to suppress a biomarker into a safe zone.
RachelRight.
MarkBut masking a symptom is miles away from actually reversing a pathology.
RachelWhich is the entire focus of today's deep dive. We are unpacking this fascinating, super detailed article from Quick Lab Mobile. It's titled, Normal Blood Sugar is not the same as diabetes remission.
MarkGreat piece.
RachelYeah, it really is. And our mission to today is to explore that exact multi-center phase three randomized trial adjustment so we can help you separate the illusion of chemical glucose control from actual disease remission.
MarkBecause treating the immediate biochemical emergency, the high blood sugar, is critical. But we need to look under the hood to see if the underlying engine is actually fixed.
The Four Drug Trial Reality Check
RachelSo let's break it down that trial because it illustrates this trap perfectly. They took 108 people recently diagnosed with type 2 diabetes to split them up. Group A gets standard care. But group B gets put on this aggressive, intensive four drug regimen on day one, like hitting it with everything they have.
MarkAnd the hypothesis there was that hitting the disease with overwhelming force across multiple mechanisms would give pancreas a massive break, right?
NicoletteExactly.
MarkThe clinical rationale for that is grounded in preventing glucotoxicity, because sustained elevated glucosis levels literally oxidize and destroy tissue.
RachelIf it's toxic, yeah.
MarkRight. It triggers cellular apopotosis, which is programmed cell death, particularly in the beta cells of the pancreas. And those are the very three cells responsible for producing insulin in the first place.
RachelSo the thought process was just to artificially crush the glucose levels immediately, using four different pathways to remove that toxic environment.
MarkYeah. Let the beta cells rest, recover, and hopefully regain their function.
RachelRight. And here's where it gets really interesting. At the 16-week mark, it looked like a slam dunk. 90% of the intense four drug group had normalized their glucose compared to 77% in standard care.
MarkWhich is a huge win on paper.
RachelTotally. But then the researchers instituted a 12-week washout period. They stopped all glucose-lowering medications to see if the bodies could maintain it.
MarkThe ultimate test.
RachelYep. And the remission rate for the four drug group plummeted to 38.3%. The standard care group actually came in higher at 43.8%.
MarkI mean, while that 5% difference might not be statistically huge, the drop itself is the revelation.
RachelIt's massive.
MarkThe agriculture pharmacology didn't repair the metabolic dysfunction at all. It just held it hostage while drugs were circulating.
RachelOkay, so is this essentially like turning up the air conditioning in a server room to hide the fact that the actual computer servers are internally overheating?
MarkThat's the perfect mechanical equivalent.
RachelRight, because the room temperature remains perfectly normal on the thermostat, so you think you've solved the problem. But the hardware is still short-circuiting.
MarkExactly. And then the second the AC cut out, the room is on fire again. The drugs acted as that industrial AC.
RachelBecause one drug forces the kidneys to excrete glucose into the urine, right?
MarkYep. And another blocks the liver from releasing storoglycogen, and another forcefully squeezed the pancreas to release more insulin. They successfully cooled the room.
RachelBut they did absolutely nothing to fix the corrupted circuits inside the servers themselves, which for us are the liver and pancreas. But let me push back on this for a second, on behalf of anyone who relies on these medications, isn't cooling the room the immediate priority? I mean, if the servers are going to melt, shouldn't we just be happy the AC works?
MarkOh, cooling the room is absolutely the first priority. Glucotoxicity damages the microvascular system, which is what leads to blindness, kidney failure, neuropathy.
RachelAaron Powell So it's saving your life in the short term.
MarkYes. We use medications to prevent immediate catastrophic hardware failure, but we cannot confuse emergency cooling with hardware repair.
RachelAh, okay. I see the distinction.
MarkAaron Ross Powell Right. If you want true remission, a state where your body natively and effortlessly regulates its own energy, you have to repair the underlying short circuit.
Why HbA1c Can Mislead
RachelAaron Powell Which brings us to the fundamental problem with how we track that repair. Because we know HBA1C is like the gold standard for tracking three-month glucose averages, right? It is, yeah. But the source points out it completely misses the intraday variability and the underlying insulin load. Let's put this in perspective for the listener.
MarkGo for it.
RachelImagine two patients. They both get an HBA1C result of 6.2%. That's below the diagnostic threshold for diabetes. On paper, their labs look identical.
MarkRight. They both look fine.
RachelBut patient A requires three different medications to force their body to hold that number, while patient B takes absolutely nothing.
MarkAaron Powell And that right there is why HBA1C provides a false equivalency.
RachelHow so?
MarkWell, patient A still has severe underlying insulin resistance. Their cells are actively rejecting insulin, and the medication is essentially a pharmacological battering RAM forcing the glucose into the cells anyway.
RachelAaron Powell Wow, so the blood looks fine, but the cells are screaming.
MarkAaron Powell Exactly. Whereas patient B has actually restored their cellular insulin sensitivity. To understand that discrepancy, we have to look past the bloodstream entirely and look at ectopic
Ectopic Fat And Beta Cell Burnout
Markfat.
RachelOkay, let's unpack this. Because the Quick Lab Mobile article heavily references the direct trial, the diabetes remission clinical trial.
MarkAaron Powell Yeah, that study shifted the entire paradigm.
RachelAaron Powell It really did. It proved that type 2 diabetes is heavily driven by fat accumulating in places it fundamentally shouldn't be. Specifically the liver and the pancreas.
MarkRight, because we tend to view fat as just this inert storage depot under the skin. Just extra weight.
RachelAaron Powell Yeah, just sitting there.
MarkBut ectopic fat is highly metabolically active and deeply disruptive. The direct trial demonstrated that patients with active type 2 diabetes had liver fat levels hovering around 16%.
RachelAaron Powell Which is dangerously high.
MarkVery. And when they underwent an intensive weight management protocol, that liver fat plummeted to just 3.1%. And when that ectopic fat cleared, the diabetes often just vanished.
RachelIt's like a factory assembly line getting completely gummed up. What is the actual mechanism there? Like why does fat in the liver stop the processing of blood sugar?
MarkIt all comes down to cellular signaling. When ectopic fat accumulates in the liver, it breaks down into lipid metabolites, specifically disylglycerols and ceramides.
RachelOkay. Big words.
MarkYeah, but just think of these molecules as literal gum shoved into the cellular keyholes. When insulin, which is the formant of the factory, shows up and binds to the cell's receptor, it's trying to send a signal to shut down glucose production. But those toxic lipid metabolites block the internal signaling pathway.
RachelSo the signal drops, the liver just becomes deaf to the insulin.
MarkYes. And because it's deaf, the liver assumes the blood is starving for energy, so it just blindly keeps pumping out unneeded glucose via gluconeogenesis, even though the blood is already saturated.
RachelThat is wild. So the pancreas senses this massive glucose buildup and goes into overdrive, right?
MarkPrecisely. It initiates compensated hyperinsulinemia. It floods the bloodstream with massive, unnatural quantities of insulin, just screaming at the liver to shut off.
RachelMeaning your blood sugar, your HBA1C, might actually look perfectly normal for years, but only because your pancreas is working brutal, unsustainable over time.
MarkAaron Powell Which is the hidden fire we were talking about. And the direct trial showed us the tragic endpoint of that fire.
RachelBecause eventually the pancreas just burns out.
MarkRight. Clearing the liver fat restores insulin sensitivity, but durable remission ultimately depends on the pancreas. Specifically, the first phase insulin response.
RachelAaron Powell That's the rapid immediate burst of insulin your pancreas releases the moment you start a meal, right? Before the glucose even has a chance to spike.
MarkExactly. In a healthy beta cell, glucose enters, generates ATP, alters the electrical charge of the membrane, and triggers this immediate release of stored insulin.
RachelRight away.
MarkBut years of glucotoxicity in ectopic fat cause beta cells to essentially lose their identity. They dedifferentiate.
RachelThey forget how to be beta cells.
MarkPretty much. If you clear the fat out of the liver, but your pancreatic beta cells have permanently lost the ability to mount that first phase electrical response, true remission is off the table.
RachelWow. So this is why early intervention is not negotiable. The patients who hit durable remission in these trials were generally those who hadn't been trapped in the disease state for decades.
MarkYes. You have to intervene while the beta cell dysfunction is still reversible before they permanently forget their job.
Personal Fat Threshold Changes Everything
RachelSo if we connect this to the bigger picture, it explains why the path to reversing this condition cannot just be a universal one size fits all prescription.
MarkWhich the source material makes very clear.
RachelYeah. There are several pathways to drain the sectopic fat and relieve the metabolic pressure. The strongest predictor, unsurprisingly, is substantial weight loss.
MarkRight. The source notes a direct dose response relationship. The more weight lost, the higher the probability of remission.
RachelMakes sense. Then we have carbohydrate restriction, which immediately lowers the daily incoming glucose load, giving that overworked pancreas a chance to breathe.
MarkYou're basically cutting off the supply lines that are fueling the glucotoxicity.
RachelThen there's exercise, specifically resistance training. The text describes skeletal muscle as a giant glucose disposal sink. Mechanistically, how is that working? Because we just said the cells are deaf to insulin.
MarkAnd this is the absolute brilliance of human physiology. Skeletal muscle contraction utilizes a completely separate backdoor to clear glucose.
RachelWait, really? A backdoor?
MarkYeah. When you lift weights or do resistance training, the mechanical contraction of the muscle activates an enzyme called AMPK.
NicoletteOkay.
MarkThis forces glucose transporters, called GLUT4 molecules, to rise to the surface of the cell and pull glucose in from the blood, completely bypassing the broken insulin signaling pathway.
RachelThat is incredible. So you are draining the glucose without needing the pancreas to shout.
MarkExactly.
RachelAnd the fourth pathway mentioned is metabolic surgery, which apparently goes far beyond just mechanically shrinking the stomach to restrict calories.
MarkOh, way beyond. Metabolic surgery fundamentally rewires gut endocrinology. Before the patient even loses a single pound, the anatomical rerouting causes a massive surge in incretant hormones like GLP1.
RachelOh, like the popular drugs right now.
MarkExactly. Right. These hormones rapidly enhance beta cell function and insulin secretion. It's a profound hormonal reset, not just a physical restriction.
RachelBut wait, you're probably wondering if this is all about losing weight and reducing fat, why do we see people who don't look obese, who are clinically thin, getting severe type 2 diabetes?
MarkThat is a great question.
RachelAnd conversely, why do some people carry a hundred extra pounds and maintain perfectly pristine metabolic blood panels?
MarkIt all comes down to a concept called the personal fat threshold.
RachelOkay, explain that.
MarkWe all have a genetically predetermined capacity for safely storing subcutaneous fat. That's the adipose tissue designed specifically for energy storage right under the skin.
RachelSo everyone has a different sized bucket for safe storage.
MarkExactly. If you have a genetically small bucket, you might only gain 10 pounds. Outwardly, you still look completely lean.
RachelBut the bucket is full.
MarkRight. And that excess energy has to be stored somewhere. So it overflows and deposits into your liver, your pancreas, and your skeletal muscle. It becomes ectopic fat.
RachelSo the thin person has overflowing ectopic fat, driving severe insulin resistance, while someone else with a massive genetic bucket might store 80 pounds safely in subcutaneous tissue, keeping their organs perfectly clean.
MarkExactly. Their glucose stays totally normal, which means remission is never about hitting an arbitrary BMI target.
RachelRight. It's strictly about dropping below your specific personal fat threshold.
MarkYes. To drain the toxic lipid metabolites from your own organs. For some, losing 5% of their body weight completely empties the liver. For others, it might take 20%.
RachelThat entirely reframes how we view body composition. It's not the aesthetic volume of the storage, it's the location.
MarkYes, location is everything.
RachelSo if we know we need to unclog the liver and rescue the pancreas, how do we track this in the
Labs That Track Real Recovery
Rachelreal world? Like if you go to your doctor, how do you look past that HBA1C smokescreen to see if your hardware is actually repairing?
MarkWell, the strict clinical definition of remission requires an HBA1C below 6.5% for at least three months, entirely without the use of any glucose-lowering medications.
RachelSo the pharmacological withdrawal is the ultimate proof of concept.
MarkIt is. But to truly measure metabolic healing, the QuifLab Mobile article details a battery of much deeper metrics.
RachelLet's dive into those, because just stopping meds and hoping for the best isn't much of a strategy. First up, fasting insulin and homego ir. We know the glucose might look beautiful, but if fasting insulin is highly elevated, it means the pancreas is still screaming.
MarkRight. And Home AR is a mathematical model that plots your fasting glucose against your fasting insulin. It gives us a highly accurate estimate of your baseline insulin resistance.
RachelSo if your glucose drops but your homin IR is still high, the ectopic fat is still gumming up the lock.
MarkExactly.
RachelWait, I'm actually a bit lost on the next one. See peptide testing. If someone is injecting synthetic insulin and it's successfully lowering their blood sugar, why does it matter if the insulin came from a syringe or their own pancreas?
MarkI mean, functionally, yes, synthetic insulin forces glucose into the cells. But diagnostically, we need to know if your pancreas is alive and dead.
RachelOkay. Morbid, but fair.
MarkWhen your native beta cells manufacture a molecule of natural insulin, they actually produce a larger precursor molecule called pro insulin.
RachelOkay.
MarkTo activate it, the cell snips off a connecting piece, which is the C peptide, and releases them both into the blood in a one-to-one ratio.
RachelAh, I get it. So synthetic insulin in a syringe has already been processed in a lab. It doesn't contain C peptide.
MarkExactly. So by measuring C peptide in your blood, we can completely ignore the synthetic insulin you injected and see exactly how much native insulin your own beta cells are still capable of producing.
RachelOh wow. If your C peptide is bottoming out, your beta cells are failing, and remission is slipping away. That is a phenomenal diagnostic tool.
MarkIt's vital.
RachelAnd to complete the picture, the source emphasizes looking at what the liver is exporting. We have liver enzyme markers, but also triglycerides and apobee. And the mechanism here is crucial. Why do triglycerides spike when blood sugar is the actual problem?
MarkBecause the liver is desperate. When the liver is choking on ectopic fat, it attempts to clear the backlog by repackaging that fat into VLDL particles. Very low density lipoprotein. Right, which are dense with triglycerides. It just dumps these into the bloodstream.
RachelSo high triglycerides on a lab panel aren't necessarily from like eating a stick of butter. They are the literal exhaust fumes of a fatty liver trying to save itself. So tracking APOB gives you a direct, unassailable count of the actual particles driving cardiovascular risk long before the HBA1C creaks back up.
MarkIt gives you total visibility.
RachelWhich is why diagnostic services like Quick Lab Mobile in Miami focus entirely on this comprehensive cardiometabolic testing. They bypass the standard superficial panels and offer at-home blood collection for these exact deep markers.
MarkFasting insulin, C. peptide APOBI, comprehensive lipids.
RachelYeah, it gives patients the empirical data to distinguish between just a controlled biomarker and genuine metabolic recovery.
MarkAnd this raises an important question regarding how we view our interventions. Utilizing medications to stop immediate microvascular damage is brilliant science. It's not a moral failure.
RachelAbsolutely not.
MarkBut the goal should always be to use that borrowed time to address the root pathology.
RachelSo what does this all mean for you listening? We've covered the mechanics of a massive paradigm shift today. We started with a trial that proved forcefully regulating a biomarker with an intense drug regimen is just not the same as changing the underlying disease architecture. We explored at topic fat, the way toxic lipid metabolites deafen the liver to insulin, and how the pancreas eventually burns out. We learned that a true remission requires dropping below your unique personal fat threshold.
MarkWhether through weight loss, car restriction, exercise, or metabolic surgery.
RachelExactly.
MarkWe have to anchor this with a very stark clinical reality. Remission is a highly conditional state. It is not an erasure of the biological vulnerability. Exactly. Your underlying susceptibility to insulin resistance is hard to coded. If you experience chronic stress, to take corticos towards loose skeletal muscle mass with age or regaining weight. If you overflow that bucket again, yeah, it topic that will immediately reburn to the liver. The beta cells be stressed again. Relapse is highly common, which is why relentless, ongoing monitoring of those deeper labs is a lifelong requirement.
RachelIt really is a permanent relationship with your metabolic data. And to wrap this up, there is one final somewhat haunting concept straight before the tech exit absolutely mull over.
Metabolic Legacy And Final Takeaways
MarkOh, this is pretty spasm.
RachelLet's just assume you excure your nectopic fat store the base cells, achieve full medication for free remission, and your blood sugar panels remain pristine for decades.
MarkThe dream scenario.
RachelRight. But the source notes that your historical exposure to that high blood sugar consistently a continuing elevated risk for kidney, retinal, and cardiovascular complications long into the future.
MarkIt's the concept of a metabolic legacy. Or p genetic memory.
RachelIt's chilling. It begs the question: does our cellular machinery keep up a permanent, invisible ledger of our metabolic history?
MarkEven when the numbers look perfect today.
RachelYeah, how much does the ghost of past high blood sugar continue to subtly rewrite our cellular destiny?
MarkIt's a profound reminder that the most critical moment to intervene in your metabolic health will always be right now, before the ledger gets any longer.
RachelAbsolutely. Thank you so much for joining us on this DD Dive.
NicoletteFor more health insights and diagnostics, visit us online at www.quicklabmobile.com. Stay informed, stay healthy, and we'll catch you in the next episode.
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
